November 23, 2020 – Baltimore, Maryland. ArmadaHealth, a leading provider of quality-based clinical navigation services for employers and the healthcare industry, is proud to be recognized as one of the most innovative companies in healthcare, according to the 2020 Inaugural List of Most Innovative Companies in Healthcare.

The 2020 listing of Most Innovative companies in healthcare includes 60 companies from 30 different categories of innovation within the medical industry. The listing was created by David Shulkin, M.D., President of Shulkin Solutions LLC and the Ninth Secretary of the US Department of Veterans Affairs. This is the first year that this list has been released.

“With a worldwide pandemic underway, we are seeing more innovation in our healthcare system than any other period in history. There never has been a more important time for our industry and this recognition is just one way of acknowledging those companies that are rising to the challenge, said Dr. Shulkin.

“ArmadaHealth is committed to improving the quality and total cost of healthcare that is delivered to patients and to the companies that we support in the healthcare system,” said Susan Torroella, CEO of ArmadaHealth.

Globally, there is increasing growth in healthcare companies. In the third quarter of 2020, there were more than 1,500 new investments into healthcare organizations totaling $21.8 billion, an increase from second quarter investments in healthcare of just over $18 billion. As the COVID-19 pandemic continues, more people are looking towards innovative ways of diagnosing and treating disease, digital engagements to improve the patient experience, and new models of care delivery.

Read the complete 2020 Most Innovative Companies in Healthcare Report by clicking here.

About ArmadaHealth®

ArmadaHealth® has developed the most robust and comprehensive physician-recommendation intelligence in the industry. Uniting oceans of data, clinical insights and a human touch, our High Tech, Right Touch® approach embodies the best practices in quality-based clinical navigation. Our proprietary enhanced intelligence platform, S.I.E.N.A.®, features multivariate quality measures and clinically trained machine-learning models as inputs to physician-patient matching algorithms. QualityCare Connect®, our flagship consumer-facing service, improves the efficiency, expediency and effectiveness of how people access perfectly matched primary and specialty-care physicians. QualityCare Navigator, our Navigation-as-a-Service offering, enables our clients’ member-facing service teams to submit, monitor and manage navigations on behalf of their members with a private-labeled solution. The result is improved health outcomes, reduced healthcare expenses and exceptional member satisfaction as reflected in our NPS of 86 while serving more than two million members. ArmadaHealth is a portfolio company of Sirius Group. Learn more at ArmadaHealth.com.

 

Cautionary Note Regarding Forward-Looking Statements

We have made statements in this press release that are forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995, including statements about the success of the strategic review and/or sale of the Company. You can identify forward-looking statements by the use of forward-looking terminology such as “plan,” “believe,” “expect,” “anticipate,” “intend,” “outlook,” “estimate,” “forecast,” “project,” “target,” “continue,” “could,” “may,” “might,” “will,” “possible,” “potential,” “predict,” “should,” “would,” “seeks,” “likely,” and other similar words and expressions, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements are based on the current expectations of the management and speak only as of the date of this document. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.

 

Press Contact:

Teresa O’Keefe
tokeefe@armadahealth.com
410-308-6782